Cetek Corporation Announces Extension of Genomic Screening Agreement With Schering-Plough Research Institute.Business Editors, Health/Medical Writers MARLBOROUGH, Mass.--(BW HealthWire)--April 25, 2001 Cetek Corporation announced today an extension of a research agreement with Schering-Plough Research Institute (SPRI SPRI Scott Polar Research Institute (University of Cambridge) SPRI Single Ply Roofing Institute SPRI Schering-Plough Research Institute (Corporate division) ) utilizing Cetek's proprietary capillary electrophoresis Capillary electrophoresis (CE), also known as capillary zone electrophoresis (CZE), can be used to separate ionic species by their charge and frictional forces. In traditional electrophoresis, electrically charged analytes move in a conductive liquid medium under the (CE) technology in screening new genomic targets. Under the extended agreement, Cetek will continue developing assays for SPRI targets and will screen these assays against libraries from SPRI. "We are pleased with the progress of our original collaboration with Schering-Plough Research Institute and are looking forward to extending our work together in genomic technology," said James N. Little, Ph.D., Senior Vice President of Cetek. "The Cetek CE Assay and our screening expertise are gaining wide acceptance for screening novel targets against both synthetic and natural product libraries." Schering-Plough Research Institute is the pharmaceutical research and development arm of Schering-Plough Corporation of Kenilworth, N.J., a research-based company engaged in the discovery, development, manufacturing and marketing of pharmaceutical products worldwide. Cetek Corporation, a privately held drug discovery company, applies its proprietary capillary electrophoresis screening technology to develop high-throughput screening High-throughput screening (HTS), is a method for scientific experimentation especially used in drug discovery and relevant to the fields of biology and chemistry. Purpose and method assays for drug targets. The Cetek CE Assay can quickly discover valuable "hits" in synthetic libraries, combinatorial mixtures, and natural product extracts. This proprietary technology combines laser-induced fluorescence
Laser-induced fluorescence (LIF) is a spectroscopic method used for studying structure of molecules, detection of selective species and flow visualization and measurements. or UV detection with high resolution CE. The CE Assay technology was originally developed in Prof. Barry Karger's laboratory at the Barnett Institute of Northeastern University Northeastern University, at Boston, Mass.; coeducational; founded 1898 as a program within the Boston YMCA, inc. 1916, university status 1922, fully independent of the YMCA 1948. and is licensed exclusively to Cetek. In addition to the CE Assay, Cetek is adding libraries, fractionation/isolation and analytical capabilities to provide identified hits to its clients. Cetek has collaborations with pharmaceutical and biotechnology companies Top 100 Biotechnology Companies The following is a list of the top 100 biotechnology companies ranked by revenue. The first nine companies qualify for the list of the top 50 pharmaceutical companies. in North America North America, third largest continent (1990 est. pop. 365,000,000), c.9,400,000 sq mi (24,346,000 sq km), the northern of the two continents of the Western Hemisphere. , Europe and Japan. For additional information, visit Cetek's website at http://www.cetek.com or contact Dr. James N. Little, Senior Vice President, at (508) 229-8900 or j.little@cetek.com. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion